The Potential Role of Pharmacogenomic and Genomic in the Adjuvant Treatment of Early Stage Non Small Cell Lung Cancer

Although notable progress has been made in the treatment of non-small-cell lung cancer (NSCLC) in recent years, this disease is still associated with a poor prognosis. Despite early-stage NSCLC is considered a potentially curable disease following complete resection, the majority of patients relapse...

Descripción completa

Detalles Bibliográficos
Autores principales: Schettino, Clorinda, Bareschino, Maria A, Maione, Paolo, Rossi, Antonio, Ciardiello, Fortunato, Gridelli, Cesare
Formato: Texto
Lenguaje:English
Publicado: Bentham Science Publishers Ltd. 2008
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2682934/
https://www.ncbi.nlm.nih.gov/pubmed/19452042
http://dx.doi.org/10.2174/138920208784533665

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2682934/
https://www.ncbi.nlm.nih.gov/pubmed/19452042
http://dx.doi.org/10.2174/138920208784533665

Ejemplares similares